Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (50)

2024

  1. Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment

    Biomedicine and Pharmacotherapy, Vol. 173

  2. Endometrial cancer: predictors and oncological safety of tumor tissue manipulation

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1098-1105

  3. Executive summary: Guidelines for the diagnosis and treatment of septic arthritis in adults and children, developed by the GEIO (SEIMC), SEIP and SECOT

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 42, Núm. 4, pp. 208-214

2023

  1. ASO Visual Abstract: Accuracy and Survival Outcomes After National Implementation of Sentinel Lymph Node Biopsy in Early-Stage Endometrial Cancer

    Annals of surgical oncology, Vol. 30, Núm. 12, pp. 7669-7670

  2. Accuracy and Survival Outcomes after National Implementation of Sentinel Lymph Node Biopsy in Early Stage Endometrial Cancer

    Annals of Surgical Oncology, Vol. 30, Núm. 12, pp. 7653-7662

  3. Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

  4. Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

    Pharmacological Research

  5. Long-term evolution in liver disease markers and immune and lipid profiles in vertically HIV/HCV-coinfected youths with sustained viral response after direct-acting antivirals therapy

    Biomedicine and Pharmacotherapy, Vol. 162

  6. Lymphovascular Space Invasion in Early-Stage Endometrial Cancer (LySEC): Patterns of Recurrence and Predictors. A Multicentre Retrospective Cohort Study of the Spain Gynecologic Oncology Group

    Cancers, Vol. 15, Núm. 9

  7. Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

    Pharmacological Research, Vol. 194

  8. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  9. What drives the decision to optimise biological treatment in children and youngsters with juvenile idiopathic arthritis? A discrete-choice experiment

    Reumatologia Clinica, Vol. 19, Núm. 1, pp. 26-33

2022

  1. Autoantibodies against type I IFNs in patients with critical influenza pneumonia

    The Journal of experimental medicine, Vol. 219, Núm. 11

  2. Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries – A study by the Joint Action on Rare Cancers

    Cancer Epidemiology, Vol. 78

  3. Oncological safety of hysteroscopy in endometrial cancer

    International Journal of Gynecological Cancer, Vol. 32, Núm. 11, pp. 1395-1401

  4. Preoperative sampling in endometrial cancer: evaluation of the histopathological agreement with definitive surgical specimen

    Clinical and Translational Oncology, Vol. 24, Núm. 12, pp. 2388-2394

2021

  1. Clinical, Immunological, and Virological Outcomes Among Youths With Perinatal HIV After Transition to Adult Units in Spain From 1997 to 2016

    Journal of acquired immune deficiency syndromes (1999), Vol. 86, Núm. 2, pp. 240-247

  2. High prevalence of variants in skeletal dysplasia associated genes in individuals with short stature and minor skeletal anomalies

    European Journal of Endocrinology, Vol. 185, Núm. 5, pp. 691-705

  3. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  4. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery

    American Journal of Obstetrics and Gynecology, Vol. 224, Núm. 1, pp. 65.e1-65.e11